CN Bio has secured a £180,000 Innovate UK grant to [...]

The FDA has accepted Belite Bio’s application for tinlarebant and [...]

Skylark Bio has dosed the first patient in a Phase [...]

CellProthera and Alfresa Holdings have signed an MOU covering potential [...]

Vaderis Therapeutics has raised $152M and started a global Phase [...]

AC Immune has received FDA Fast Track designation and IND [...]

Bios Life has emerged from stealth with $25M in seed [...]

Calla Lily Clinical Care has been selected for Wellcome Leap’s [...]

Oncoinvent has published Phase 1 dosimetry data for Radspherin in [...]

Alamar Biosciences is expanding a partnership with the Alzheimer’s Disease [...]